Histogenics (HSGX) Tops Q1 EPS by 8c

Histogenics (NASDAQ: HSGX) reported Q1 EPS of ($0.27), $0.08 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Histogenics (HSGX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance